Declining use of red blood cell transfusions for gastrointestinal cancer surgery: A population-based analysis.

Authors

null

Jesse Zuckerman

Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada

Jesse Zuckerman , Natalie Coburn , Jeannie Callum , Alyson Mahar , Victoria Zuk , Yulia Lin , Robin McLeod , Alexis F. Turgeon , Emily Pearsall , Guillaume Martel , Julie Hallet

Organizations

Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada, Odette Cancer Centre, Sunnybrook Hospital, Toronto, ON, Canada, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, University of Manitoba, Winnipeg, MB, Canada, Sunnybrook Research Institute, Toronto, ON, Canada, Cancer Care Ontario, Toronto, ON, Canada, CHU de Quebec, Quebec, QC, Canada, Department of Surgery, University of Toronto, Toronto, ON, Canada, Ottawa Hospital, Ottawa, ON, Canada, Odette Cancer Centre, Toronto, ON, Canada

Research Funding

Other Government Agency
Canadian Institute of Health Research, Other Foundation

Background: Perioperative anemia is common in gastrointestinal (GI) cancer surgery patients and is often treated with red blood cell transfusion (RBCT), which carries risks for inferior oncologic outcomes. Despite level-1 evidence for restrictive transfusion strategies, RBCT use is often not consistent with guidelines leading to a high rate of unnecessary transfusions. Understanding of RBCT use at the population-level is necessary to develop system-level efforts to minimize perioperative RBCT for cancer. We sought to evaluate the secular trends of transfusion in a large North American population. Methods: We conducted a population-based retrospective cohort study of patients undergoing GI cancer resection between 2007-2018 using linked administrative health datasets in Ontario, Canada. Primary outcome was administration of any RBCT during the hospitalization. Temporal RBCT trends were analyzed with Cochran-Armittage tests for trend. Modified Poisson regression assessed trends while controlling for potential confounders. Results: Of 79,764 patients undergoing GI cancer resection, median age was 69 (IQR: 60-78) years old and 55.5% were male. The most frequent cancer site was colorectal cancer (n = 63,243), followed by esophago-gastric (n = 7,307), hepato-pancreato-biliary (n = 6,510), and small bowel (n = 2,704). 30% of patients received RBCT. The proportion of patients transfused decreased from 26.5% in 2007 to 18.9% in 2018 (p < 0.001). This trend remained consistent when stratified by sex, age, cancer type, operative approach, procedure setting, and institution teaching status. After adjusting for patient and institution factors, the time period was associated with receipt of RBCT with a relative risk of 0.94 (95% CI 0.91-0.96) for 2011-14 and 0.75 (95% CI 0.73-0.78) for 2015-2018 compared to the period of 2007-10. Conclusions: Over the 11-year study period, we observed a decrease in RBCT for GI cancer resection. These findings may reflect the dissemination of clinical guidelines and implementation of patient blood management programs. An evaluation of institutional variation and the relationship with outcomes is warranted to identify opportunities for further improvement.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2020 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Esophageal and Gastric Cancer and Other GI Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Patient-Reported Outcomes and Real-World Evidence

Citation

J Clin Oncol 38, 2020 (suppl 4; abstr 802)

Abstract #

802

Poster Bd #

J6

Abstract Disclosures

Similar Abstracts

First Author: Jesse Zuckerman

Abstract

2024 ASCO Gastrointestinal Cancers Symposium

Use of micronuclei DNA from erythrocytes in early-stage colorectal cancer detection.

First Author: Xingyun Yao

First Author: Mae Alghawas